Ellen M Tedaldi

Summary

Affiliation: Temple University
Country: USA

Publications

  1. ncbi Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy
    Ellen M Tedaldi
    Temple University Hospital, Section of General Internal Medicine, Philadelphia, Pennsylvania 19140, USA
    Clin Infect Dis 36:363-7. 2003
  2. ncbi Hepatitis A and B vaccination practices for ambulatory patients infected with HIV
    Ellen M Tedaldi
    General Internal Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140, USA
    Clin Infect Dis 38:1478-84. 2004
  3. ncbi Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients
    Ellen M Tedaldi
    Temple University School of Medicine, Philadelphia, PA 19140, USA
    J Acquir Immune Defic Syndr 43:35-41. 2006
  4. ncbi Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS
    Ellen M Tedaldi
    Temple University School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Infect Dis 36:1313-7. 2003
  5. ncbi New drug targets for HIV and hepatitis C virus coinfection
    Ellen M Tedaldi
    Comprehensive HIV Program, Temple University School of Medicine, Philadelphia, PA 19140, USA
    Clin Infect Dis 41:S101-4. 2005
  6. ncbi CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression
    Tracy Fischer-Smith
    Department of Neuroscience, Temple University School of Medicine, Philadelphia, Pennsylvania 19122, USA
    AIDS Res Hum Retroviruses 24:417-21. 2008
  7. ncbi Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study)
    Ellen M Tedaldi
    Temple Comprehensive HIV Program, Temple University School of Medicine, Philadelphia, PA 19140, USA
    J Acquir Immune Defic Syndr 47:441-8. 2008
  8. ncbi Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States
    Ellen M Tedaldi
    Temple University School of Medicine, Philadelphia, PA, USA
    AIDS Patient Care STDS 26:718-29. 2012
  9. ncbi Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies
    Ellen M Tedaldi
    Temple Comprehensive HIV Program, Temple University Hospital, 1316 West Ontario Street, Philadelphia, PA 19140, USA
    J Addict Dis 27:83-91. 2008
  10. ncbi Grade 4 events are as important as AIDS events in the era of HAART
    Ronald B Reisler
    Institute of Human Virology, University of Maryland, Baltimore, MD 21201, USA
    J Acquir Immune Defic Syndr 34:379-86. 2003

Collaborators

Detail Information

Publications13

  1. ncbi Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy
    Ellen M Tedaldi
    Temple University Hospital, Section of General Internal Medicine, Philadelphia, Pennsylvania 19140, USA
    Clin Infect Dis 36:363-7. 2003
    ..HAART use was a strong predictor of increased duration of survival, suggesting that treatment is more important to survival than is HCV coinfection status...
  2. ncbi Hepatitis A and B vaccination practices for ambulatory patients infected with HIV
    Ellen M Tedaldi
    General Internal Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140, USA
    Clin Infect Dis 38:1478-84. 2004
    ....
  3. ncbi Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients
    Ellen M Tedaldi
    Temple University School of Medicine, Philadelphia, PA 19140, USA
    J Acquir Immune Defic Syndr 43:35-41. 2006
    ....
  4. ncbi Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS
    Ellen M Tedaldi
    Temple University School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Infect Dis 36:1313-7. 2003
    ..The prevalence of HCV coinfection in a diverse HIV clinical trials cohort provides additional information about risk behaviors and demographic factors that can be used in the analysis of clinical and virologic outcomes...
  5. ncbi New drug targets for HIV and hepatitis C virus coinfection
    Ellen M Tedaldi
    Comprehensive HIV Program, Temple University School of Medicine, Philadelphia, PA 19140, USA
    Clin Infect Dis 41:S101-4. 2005
    ..Strategic treatment trials that address sequencing of HCV and HIV therapy with current and future therapeutic agents and combination therapy need to be undertaken...
  6. ncbi CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression
    Tracy Fischer-Smith
    Department of Neuroscience, Temple University School of Medicine, Philadelphia, Pennsylvania 19122, USA
    AIDS Res Hum Retroviruses 24:417-21. 2008
    ..CD163(+)/CD16(+) monocytes may be a useful biomarker for HIV-1 infection and AIDS progression and a possible target for therapeutic intervention...
  7. ncbi Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study)
    Ellen M Tedaldi
    Temple Comprehensive HIV Program, Temple University School of Medicine, Philadelphia, PA 19140, USA
    J Acquir Immune Defic Syndr 47:441-8. 2008
    ..Differences in adverse events by gender and race/ethnicity have not been described extensively in randomized clinical trials of HIV antiretroviral therapy (ART)...
  8. ncbi Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States
    Ellen M Tedaldi
    Temple University School of Medicine, Philadelphia, PA, USA
    AIDS Patient Care STDS 26:718-29. 2012
    ..Self-administered computerized standardized screening tools can identify at-risk individuals with depression who may benefit from interventions to improve antiretroviral adherence...
  9. ncbi Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies
    Ellen M Tedaldi
    Temple Comprehensive HIV Program, Temple University Hospital, 1316 West Ontario Street, Philadelphia, PA 19140, USA
    J Addict Dis 27:83-91. 2008
    ..The new treatment choices in HIV will need to ensure effective and durable viral suppression especially against highly resistant virus strains, regimen tolerability and improved toxicity...
  10. ncbi Grade 4 events are as important as AIDS events in the era of HAART
    Ronald B Reisler
    Institute of Human Virology, University of Maryland, Baltimore, MD 21201, USA
    J Acquir Immune Defic Syndr 34:379-86. 2003
    ....
  11. ncbi Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005
    Kate Buchacz
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 22:1345-54. 2008
    ..To assess temporal trends in the rates of hospitalizations and associated diagnoses among HIV-infected patients before and during the era of highly active antiretroviral therapy...
  12. ncbi Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial
    William Burman
    Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA
    J Acquir Immune Defic Syndr 49:142-50. 2008
    ..To compare the HIV transmission risk among patients randomized to episodic versus continuous antiretroviral therapy...
  13. ncbi Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003
    Pragna Patel
    Centers for Disease Control and Prevention, Emory University, and Northrop Grumman Information Technology, Atlanta, Georgia 30333, USA
    Ann Intern Med 148:728-36. 2008
    ..Persons who are HIV-infected may be at higher risk for certain types of cancer than the general population...